<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04862390</url>
  </required_header>
  <id_info>
    <org_study_id>NRJ21J/034/02</org_study_id>
    <nct_id>NCT04862390</nct_id>
  </id_info>
  <brief_title>Incidence of Hypoglycemia in Pregnant Ladies With or Without Gestational Diabetes Fasting Ramadan</brief_title>
  <official_title>Incidence of Hypoglycemia in Pregnant Women With or Without Diabetes During Fasting in Ramadan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The physiological change in food and sleep pattern during Ramadan impacted hypoglycemia risks&#xD;
      among pregnant women. Few studies investigated the incidence of hypoglycemia pregnant women&#xD;
      with or without diabetes during fasting in Ramadan in Saudi Arabia. This study aims to&#xD;
      understand the glucose variability in pregnant women during fasting Ramadan in Saudi Arabia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with normal pregnancy will be compared to women with gestational diabetes on diet or&#xD;
      Metformin alone during Fasting Ramadan. They will be monitored and will be observed for&#xD;
      incidence of hypoglycemia using continuous glucose monitoring devices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 28, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 27, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoglycemia incidence with fasting</measure>
    <time_frame>1 month</time_frame>
    <description>To estimate the incidence of hypoglycemia defined as blood glucose &lt; 70 mg/dl during fasting in pregnant women with gestational diabetes on diet therapy or metformin alone compared to women without diabetes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose variability during fasting Ramadan</measure>
    <time_frame>1 month</time_frame>
    <description>To estimate the difference in the groups in glucose variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days that needed to break fasting</measure>
    <time_frame>1 month</time_frame>
    <description>To estimate the difference in the groups in number of days that needed to break fasting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in range (TIR)</measure>
    <time_frame>1 month</time_frame>
    <description>TIR is defined as blood glucose range between 63-140 mg/dl (3.5-7.8 mmol/L) according to ADA guideline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time above range (TAR)</measure>
    <time_frame>1 month</time_frame>
    <description>TAR that defined as blood glucose range &gt;140 mg/dl (&gt;7.8 mmol/L) according to ADA guideline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time below range (TBR)</measure>
    <time_frame>1 month</time_frame>
    <description>TBR that defined as blood glucose range &lt; 60 mg/dl</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pregnancy in Diabetic</condition>
  <arm_group>
    <arm_group_label>Normal Pregnancy</arm_group_label>
    <description>Pregnant women with no diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gestational diabetes on diet alone</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Gestational diabetes on diet + Metformin therapy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous glucose monitoring</intervention_name>
    <description>Home continuous glucose monitoring to be installed for two weeks during fasting Ramadan</description>
    <arm_group_label>Gestational diabetes on diet + Metformin therapy</arm_group_label>
    <arm_group_label>Gestational diabetes on diet alone</arm_group_label>
    <arm_group_label>Normal Pregnancy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant ladies without gestational diabetes (GDM) and with GDM on diet or metformin&#xD;
        attending the endocrine and obstetric clinics at National Guards Hospital Jeddah, and who&#xD;
        intend to fast Ramadan will be recruited over 2 months period prior to Ramadan. Those who&#xD;
        accept and fulfill the inclusion criteria will be consented to participate. During Ramadan&#xD;
        they will be requested to do home glucose monitoring which is part of standard of care and&#xD;
        will also be put on glucose sensors for 14 days, after which reprots will be downloaded&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt; 18 years old.&#xD;
&#xD;
          2. Pregnant women without diabetes.&#xD;
&#xD;
          3. Pregnant women with diabetes (pregestational and gestational) on diet +/- metformin.&#xD;
&#xD;
          4. Dedicated to applying a continuous glucose monitoring (CGM) device.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age below18 years&#xD;
&#xD;
          2. Pregnant women with diabetes on insulin (type 1 and type 2 diabetes)&#xD;
&#xD;
          3. Renal and liver impairment.&#xD;
&#xD;
          4. Adrenal insufficiency&#xD;
&#xD;
          5. Psychiatric diseases.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Reem M Alamoudi</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Abdullah International Medical Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reem M Alamoudi</last_name>
    <phone>0122266666</phone>
    <email>amoudir@ngha.med.sa</email>
  </overall_contact>
  <location>
    <facility>
      <name>KingAbullahIMRC</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reem M Alamoudi</last_name>
      <phone>966505641595</phone>
      <email>amoudir@ngha.med.sa, refal2001@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnant, gestational diabetes, fasting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

